Table 2.

Clinical response and OS after therapy with ipilimumab

Tumor response after Ipi therapy according to irRCn (%)
Best overall response
 Complete response1 (2)
 Partial response5 (8)
 Stable disease17 (29)
 Progressive disease36 (61)
 Disease control rate23 (39)
OS (mo)
 Median OS (95% CI)9.8 (5.7–14.1)
 6 mo OS (%)45.2
 12 mo OS (%)35.7
 24 mo OS (%)18.9

Abbreviation: mo, months.